All news from our members

Find information about Interpharma and its members here: from social media to press releases and stories. Scroll down for the press archive. Click through the latest posts from our members and partners.

Furthermore, you can view facts and figures about the Swiss healthcare and pharmaceutical landscape in our datacenter.

Press archive

Interpharma and its members in the press.
Here you will find the press releases and stories of our members in Switzerland.


AstraZeneca Media Release de

4 November 2021

Update zum Zulassungsantrag für den COVID-19-Impfstoff von AstraZeneca in der...

AstraZeneca hat sich entschlossen, die Marktzulassung für ihren COVID-19-Impfstoff in der Schweiz nicht weiter zu verfolgen. Dieser...

Viforpharma Media Release en

27 October 2021

Vifor Pharma and Angion report topline results from phase-III registration trial...

Novartis Media Release de

26 October 2021

Novartis erzielt im dritten Quartal solide Ergebnisse – mit starkem Wachstum...

Novartis Media Release fr

26 October 2021

Novartis réalise de solides résultats au 3e trimestre, avec une forte...

Novartis Media Release de

21 October 2021

Novartis unterzeichnet neue Erst-Vereinbarung mit BioNTech zur Unterstützung...

Sie interessieren sich für offene Stellen bei Novartis? Besuchen Sie unseren Karrierebereich. Zurück

Novartis Media Release fr

21 October 2021

Novartis annonce un nouvel accord de coopération avec BioNTech pour aider à...

Vous recherchez des postes chez Novartis ? Visitez notre section Carrières. Retour à la page précédente

Roche Media Release de

15 October 2021

Roche informiert über die befristete Swissmedic-Zulassung von Gavreto...

Roche gab heute bekannt, dass das Schweizerische Heilmittelinstitut (Swissmedic) Gavreto(R) (Pralsetinib) eine befristete Zulassung für...

Roche Media Release en

15 October 2021

Roche announces Swissmedic temporary approval of Gavreto (pralsetinib) for...

Roche today has announced that the Swiss agency for therapeutic products (Swissmedic) has granted a temporary approval for Gavreto(R)...

Roche Media Release fr

15 October 2021

Roche annonce l’autorisation à durée limitée par Swissmedic de Gavreto...

Roche a annoncé aujourd’hui que l’Institut suisse des produits thérapeutiques (Swissmedic) a accordé Gavreto(R) (pralsétinib) une...

Your search query did not produce any results.

load more

About us

Interpharma, the association of Switzerland’s research-based pharmaceutical industry, was founded in Basel in 1933.

Interpharma informs the public about issues that are important to the research-based pharmaceutical industry in Switzerland, including the pharma market in Switzerland, healthcare and biomedical research.

Annual report

Information on our key figures and activities in the financial year 2020

read more

Board and Executive Management

Introducing Interpharma

read more

Vision and Mission

More about the tasks and overriding aims of Interpharma

read more

Contact

Contact us

read more

Media

Latest information and media contacts for media representatives

read more